Difenoxin
Motofen (difenoxin) is a small molecule pharmaceutical. Difenoxin was first approved as Motofen on 1982-01-01. It is used to treat diarrhea in the USA.
Download report
Favorite
Commercial
Therapeutic Areas
Therapeutic Area | MeSH |
---|---|
signs and symptoms pathological conditions | D013568 |
Trade Name
FDA
EMA
Combinations
Motofen
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Atropine sulfate
+
Difenoxin hydrochloride
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
MOTOFEN | Sebela Pharmaceuticals | N-017744 RX | 1982-01-01 | 1 products, RLD, RS |
Show 1 discontinued
Labels
FDA
EMA
Brand Name | Status | Last Update |
---|---|---|
motofen | New Drug Application | 2018-12-14 |
Indications
FDA
EMA
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
diarrhea | HP_0002014 | D003967 | R19.7 |
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
HCPCS
No data
Clinical
Clinical Trials
1 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Obesity | D009765 | EFO_0001073 | E66.9 | — | — | — | 1 | — | 1 |
Indications Phases 3
No data
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name | DIFENOXIN |
INN | difenoxin |
Description | Difenoxin is a piperidinemonocarboxylic acid that is 4-phenylpiperidine-4-carboxylic acid in which the hydrogen attached to the nitrogen atom is substituted by a 3-cyano-3,3-diphenylpropyl group. It has a role as an antidiarrhoeal drug. It is a piperidinemonocarboxylic acid, a tertiary amine and a nitrile. |
Classification | Small molecule |
Drug class | fluoroquinolone derivatives, nonantibacterial indication (e.g., antineoplastic antibiotics) |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | N#CC(CCN1CCC(C(=O)O)(c2ccccc2)CC1)(c1ccccc1)c1ccccc1 |
Identifiers
PDB | — |
CAS-ID | 28782-42-5 |
RxCUI | 23024 |
ChEMBL ID | CHEMBL1201321 |
ChEBI ID | 4534 |
PubChem CID | 34328 |
DrugBank | DB01501 |
UNII ID | 3ZZ5BJ9F2Q (ChemIDplus, GSRS) |
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 35 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
1,068 adverse events reported
View more details
Premium feature
Learn more about premium features at pharmakb.com
Learn more